These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 8498899)
1. Multicenter study with recombinant human erythropoietin. Tanaka H; Kan E; Takegaki Y; Inariba H; Yoshimoto M; Ohno Y; Maekawa M; Tatsumi N; Kishimoto T Artif Organs; 1993 Apr; 17(4):213-8. PubMed ID: 8498899 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum. Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507 [TBL] [Abstract][Full Text] [Related]
3. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients]. Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783 [TBL] [Abstract][Full Text] [Related]
4. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project. Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration. Eisele G; Bailie GR; Clement C; Wong E Perit Dial Int; 1992; 12(1):34-6. PubMed ID: 1543777 [TBL] [Abstract][Full Text] [Related]
6. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO). Campos A; Garin EH Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282 [TBL] [Abstract][Full Text] [Related]
7. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis]. Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643 [TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N; Osman-Malik Y; Frinak S; Besarab A Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [TBL] [Abstract][Full Text] [Related]
9. Trends in anemia management among US hemodialysis patients. Coladonato JA; Frankenfield DL; Reddan DN; Klassen PS; Szczech LA; Johnson CA; Owen WF J Am Soc Nephrol; 2002 May; 13(5):1288-95. PubMed ID: 11961017 [TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients. Nissenson AR; Berns JS; Sakiewicz P; Ghaddar S; Moore GM; Schleicher RB; Seligman PA Am J Kidney Dis; 2003 Aug; 42(2):325-30. PubMed ID: 12900815 [TBL] [Abstract][Full Text] [Related]
11. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group. Nissenson AR Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075 [TBL] [Abstract][Full Text] [Related]
12. Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin. Jones-Lecointe A; Green PJ; Lee HA Clin Lab Haematol; 1991; 13(3):251-3. PubMed ID: 1794227 [TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients. Charytan C; Goldfarb-Rumyantzev A; Wang YF; Schwenk MH; Spinowitz BS Am J Nephrol; 1998; 18(6):498-503. PubMed ID: 9845824 [TBL] [Abstract][Full Text] [Related]
14. Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload. Lin CL; Hsu PY; Yang HY; Huang CC Ren Fail; 2003 May; 25(3):445-53. PubMed ID: 12803508 [TBL] [Abstract][Full Text] [Related]
15. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report. Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336 [TBL] [Abstract][Full Text] [Related]
16. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study. Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA; BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis. Shrivastava D; Rao TK; Sinert R; Khurana E; Lundin AP; Friedman EA Am J Kidney Dis; 1995 Jun; 25(6):904-9. PubMed ID: 7771487 [TBL] [Abstract][Full Text] [Related]
18. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study]. Sinnassamy P; Andre JL; Treize G; Leroy B Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412 [TBL] [Abstract][Full Text] [Related]
19. Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients. Greenbaum LA; Pan CG; Caley C; Nelson T; Sheth KJ Pediatr Nephrol; 2000 Sep; 14(10-11):908-11. PubMed ID: 10975297 [TBL] [Abstract][Full Text] [Related]
20. Clinical effects of recombinant human erythropoietin in hemodialysis patients. Results of the "Abruzzo" Multicenter Trial. Di Paolo B; Di Liberato L; Summa R; Catucci G; Del Rosso G; Muscianese P; Albertazzi A ASAIO Trans; 1991; 37(3):M380-1. PubMed ID: 1751197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]